NCT02587572View on ClinicalTrials.gov

Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Metabolic DiseaseEndothelial Dysfunction
Interventions
BIOLOGICAL

Peripheral Intravenous (IV) infusion of LMSCs

Peripheral Intravenous (IV) infusion of LMSCs

Sponsors

Lead Sponsor

Longeveron Inc.
All Listed Sponsors
lead

Longeveron Inc.

INDUSTRY

NCT02587572 - Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial | Biotech Hunter | Biotech Hunter